iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Akums Drugs IPO closing today; oversubscribed 9 times

1 Aug 2024 , 12:28 PM

On day 3 of bidding, Akums Drugs and Pharmaceuticals’ initial public offering (IPO) was subscribed 9.04 times overall by 12.20 pm. Retail Individual Investors (RIIs) led the charge, subscribing to 13.32 times their allocated share. Non-institutional investors (NIIs) followed with a subscription rate of nearly 21.46 times, while Qualified Institutional Buyers (QIBs) subscribed 1.59 times their quota. The employee segment also saw healthy participation, with a subscription rate of 3 times.

The IPO, targeting to raise ₹1,856.74 Crore, is set to close on August 1. The shares are expected to debut on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on August 6. The offering includes a fresh issue of 1 Crore shares valued at ₹680 Crore and an offer for sale (OFS) of 1.73 Crore shares, amounting to ₹1,176.74 Crore. The price band for the shares is set between ₹646 and ₹679 each.

Significant interest from anchor investors has already been secured, with ₹828.78 Crore raised on the anchor bid date of July 29. The proceeds from the IPO will be utilized to repay debts of the company and its subsidiaries, enhance working capital, pursue growth through acquisitions, and meet general corporate expenses.

ICICI Securities Ltd, Axis Bank Ltd, Citigroup Global Markets India Pvt Ltd, and Ambit Pvt Ltd are the book-running lead managers for the IPO, with Link Intime India Pvt Ltd serving as the registrar.

Founded in 2004, Akums Drugs and Pharmaceuticals is a leading pharmaceutical contract development and manufacturing organization (CDMO). The company also manufactures and sells branded drugs and active pharmaceutical ingredients (APIs). Despite a 13.81% increase in revenue for the fiscal year ending March 31, 2024, Akums reported a significant 99.19% decline in profit after tax (PAT) compared to the previous year.

 

Related Tags

  • Akums Drugs and Pharmaceuticals
  • Akums Drugs IPO
  • Akums Drugs ipo details
  • Akums Drugs IPO last day
  • Akums Drugs IPO news
  • Akums Drugs IPO price
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.